BioSig to Participate in the The Benchmark Company 10th Annual Discovery Conference
Westport, CT, Nov. 17, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the more...
Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis
New indication expands addressable market for Pantheris REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for more...
HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies TUCSON, Ariz., Nov. 17, 2021 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative more...
BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights
Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System for Treatment of Anxious Depression Conference Call to be held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Nov. more...
Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test
HAUPPAUGE, N.Y., Nov. 16, 2021 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the U.S. more...
BioSig Initiates Artificial Intelligence Development Program with Technion – Israel Institute of Technology
Company partners with the leading academic institution on research and development of AI-driven methods for atrial fibrillation procedures Westport, CT, Nov. 16, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), more...
Assertio (ASRT) Shows Fast-paced Momentum But Is Still a Bargain Stock
Momentum investors typically don’t time the market or “buy low and sell high.” In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that “buying high more...
Aesthetic Medical International Holdings Group Limited Reports Second Quarter and First Half of 2021 Unaudited Financial Results
SHENZHEN, China, Nov. 16, 2021 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced its unaudited financial results more...
ENDRA Life Sciences Inc. (NDRA) Reports Q3 Loss, Misses Revenue Estimates
ENDRA Life Sciences Inc. (NDRA) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.15 per share a year more...
Annovis Bio Announces Transfer of Listing to the New York Stock Exchange
Trading to begin November 18, 2021 with current ticker “ANVS” Berwyn, Pennsylvania–(Newsfile Corp. – November 15, 2021) – Annovis Bio, Inc. (NYSE American: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company addressing Alzheimer’s more...